🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial studies the side effects of IRX-2, cyclophosphamide,...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-04-19
Trial ID
NCT03918499
Treatments Being Tested
The purpose of this study is to determine whether a pre-operative regimen o...
Status
Completed
Location
Banner University Medical Center
Start Date
2016-01-11
Trial ID
NCT02609386
Treatments Being Tested
The goal of this study is assess the safety and tolerability of the IRX-2 r...
Status
Completed
Location
Providence Portland Medical Center
Start Date
2017-02-09
Trial ID
NCT02950259
Treatments Being Tested
This study is to determine the safety of IRX-2 Regimen combined with Nivolu...
Status
Completed
Location
H Lee Moffitt Cancer Center and Research Institute
Start Date
2019-02-13
Trial ID
NCT03758781
The purpose of this study is to see if the IRX-2 regimen and Durvalumab, wi...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2019-08-21
Trial ID
NCT03381183
Treatments Being Tested
This randomized phase II trial studies how well an IRX-2 Regimen works in t...
Status
Terminated
Location
USC / Norris Comprehensive Cancer Center
Start Date
2017-11-08
Trial ID
NCT03267680
This phase Ib trial studies the side effects and best dose of IRX-2 when gi...
Status
Active Not Recruiting
Location
HonorHealth Research Institute
Start Date
2019-05-17
Trial ID
NCT03655002
Treatments Being Tested
This was a Phase 2a trial to investigate the safety and biological activity...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00210470
Treatments Being Tested